Kissebah AH, Krakower GRRegional adiposity and morbidity. Physiol Rev1994;74:761-811.
2.
Kanai H., Matsuzawa Y., Kotani K. et al. Close correlation of intra-abdominal fat accumulation to hypertension in obese women.Hypertension1990;16:484-90.
3.
Rocchini APCardiovascular regulation in obesity-induced hypertension. Hypertension1992;19 (Suppl):156-160.
4.
Ferrannini E.The haemodynamics of obesity: a theoretical analysis . J Hypertens1992;10:1417-23.
5.
Carroll JF, Dwyer TM, Grady AW et al. Hypertension, cardiac hypertrophy, and neurohumoral activity in a new animal model of obesity. Am J Physiol1996;271:H373-H378.
6.
Koch R., Sharma AMObesity and cardiovascular hemodynamic function. Curr Hypertens Rep1999;1:127-30.
7.
Scherrer U., Sartori C.Insulin as a vascular and sympathoexcitatory hormone: Implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity . Circulation1997;96:4104-13.
8.
Landsberg L.Obesity-related hypertension and the insulin resistance syndrome. Trans Am Clin Climatol Assoc1994;106:69-75.
9.
Mikhail N., Golub MS,Tuck MLObesity and hypertension. Prog Cardiovasc Dis1999;42:39-58.
Hall JE, Brands MW, Henegar JRMechanisms of hypertension and kidney disease in obesity. Ann N Y Acad Sci1999; 892:91-107.
12.
Reisin E.Sodium and obesity in the pathogenesis of hypertension. Am J Hypertens1990;3:164-7.
13.
Carroll JF, Huang M., Hester RL, Cockrell K., Mizelle HLHemodynamic alterations in hypertensive obese rabbits. Hypertension1995;26:465-70.
14.
Crandall DL , Goldstein BM, Lizzo FH, Gabel RA, Cervoni P.Hemodynamics of obesity: influence of pattern of adipose tissue cellularity. Am J Physiol1986;251:R314-R319.
15.
Hall JE, Brands MW, Dixon WN, Smith MJ, Jr.Obesity-induced hypertension: renal function and systemic hemodynamics . Hypertension1993;22:292-9.
16.
Granger JP, West D., Scott J.Abnormal pressure natriuresis in the dog model of obesity-induced hypertension . Hypertension1994;23 (Suppl):18-111.
17.
Suzuki H., Ikenaga H., Hayashida T. et al. Sodium balance and hypertension in obese and fatty rats. Kidney Int Suppl1996;55:S150-S153.
18.
Fujiwara K. , Hayashi K., Matsuda H. et al. Altered pressure-natriuresis in obese Zucker rats. Hypertension1999;33:470-5.
19.
Dwyer TM, Banks SA, Alonso-Galicia M. et al. Distribution of renal medullary hyaluronan in lean and obese rabbits. Kidney Int2000;58:721-9.
20.
Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJDevelopment of hypertension in a rat model of diet-induced obesity . Hypertension2000;35:1009-15.
21.
Alonso-Galicia M., Dwyer TM, Herrera GA, Hall JEIncreased hyaluronic acid in the inner renal medulla of obese dogs.Hypertension1995;25:888-92.
22.
Rumantir MS ,Vaz M., Jennings GL et al. Neural mechanisms in human obesity-related hypertension. J Hypertens1999;17:1125-33.
23.
Vaz M., Jennings G., Turner A., Cox H., Lambert G., Esler M.Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation1997 ;96:3423-9.
24.
Hall JE, Brands MW, Hildebrandt DA, Kuo J., Fitzgerald S.Role of sympathetic nervous system and neuropeptides in obesity hypertension . Braz J Med Biol Res2000;33:605-18.
25.
Mark AL, Correia M., Morgan DA, Shaffer RA, Haynes WGObesity-induced hypertension: new concepts from the emerging biology of obesity . Hypertension1999;33:537-41.
26.
Carlson SH, Shelton J., White CR, Wyss JMElevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension2000;35:403-8.
27.
Kassab S., Kato T., Wilkins FC, Chen R., Hall JE, Granger JPRenal denervation attenuates the sodium retention and hypertension associated with obesity.Hypertension1995;25:893-7.
28.
Huang WC, FangTC,Cheng JTRenal denervation prevents and reverses hyperinsulinemia-induced hypertension in rats. Hypertension1998;32:249-54.
29.
Dessì-Fulgheri P., Sarzani R.,Tamburrini P. et al. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens1997;15:1695-9.
30.
Licata G., Volpe M., Scaglione R., Rubattu S.Salt-regulating hormones in young normotensive obese subjects: Effects of saline load. Hypertension1994;23 (Suppl):120-124.
31.
Sarzani R., Paci VM, Zingaretti CM et al. Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue. J Hypertens1995;13:1241-6.
32.
Crandall DL , Ferraro GD, Cervoni P.Effect of experimental obesity and subsequent weight reduction upon circulating atrial natriuretic peptide. Proc Soc Exp Biol Med1989;191:352-6.
33.
Dessi-Fulgheri P., Sarzani R., Serenelli M. et al. Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives . Hypertension1999; 33:658-62.
34.
Dessi-Fulgheri P., Sarzani R., Rappelli A.The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects. J Nephrol1998;11:296-9.
35.
Jeunemaitre X., Soubrier F., Kotelevtsev YV et al. Molecular basis of human hypertension: role of angiotensinogen. Cell1992;71:169-80.
36.
Kunz R., Kreutz R., Beige J., DistlerA,Sharma AMAssociation between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension1997; 30:1331-7.
37.
Jeunemaitre X., Inoue I., Williams C. et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet1997;60:1448-60.
38.
Hegele RA, Brunt JH, Connelly PWGenetic variation on chromosome 1 associated with variation in body fat distribution in men. Circulation1995;92:1089-93.
39.
Hopkins PN, Lifton RP, Hollenberg NK et al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens1996;14:199-207.
40.
Rankinen T. , Gagnon J., Perusse L.Body fat, resting and exercise blood pressure and the angiotensinogen M235T polymorphism : the heritage family study. Obes Res1999;7:423-30.
41.
Hunt SC, Cook NR, Oberman A. et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. Hypertension1998;32:393-401.
42.
Ishigami T. ,Tamura K., Fujita T. et al. Angiotensinogen gene polymorphism near transcription start site and blood pressure: role of a T-to-C transition at intron I. Hypertension1999;34:430-4.
43.
Rice T., Rankinen T., Province MA et al. Genome-wide linkage analysis of systolic and diastolic blood pressure. Circulation2000;102:1956-63.
44.
Cooper RS, Guo X., Rotimi CN et al. Heritability of angiotensin-converting enzyme and angiotensinogen: A comparison of US blacks and Nigerians. Hypertension2000;35:1141-7.
45.
Cooper R., Forrester T., Ogunbiyi O., Muffinda J.Angiotensinogen levels and obesity in four black populations. J Hypertens1998;16:571-5.
46.
Rocchini AP , Key J., Bondie D. et al.The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents .NEnglJMed1989;321:580-5.
47.
Egan BM, Stepniakowski K., Goodfriend TLRenin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering. Am J Hypertens1994;7:886-93.
Goodfriend TL, Egan BM, Kelley DEPlasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. Prostaglandins Leukot Essent Fatty Acids1999;60:401-5.
50.
Cooper R., McFarlane Anderson N. et al.ACE, angiotensinogen and obesity: a potential pathway leading to hypertension. J Hum Hypertens1997;11:107-11.
51.
Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JHThe serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest1995;95:948-53.
52.
Umemura S., Nyui N.,Tamura K. et al. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens1997;10:629-33.
53.
Schorr U., Blaschke K., Turan S., Distler A., Sharma AMRelationship between angiotensinogen, leptin and blood pressure levels in young normotensive men. J Hypertens1998 ;16:1475-80.
54.
Uckaya G., Ozata M., Sonmez A. et al. Plasma leptin levels strongly correlate with plasma renin activity in patients with essential hypertension. Horm Metab Res1999;31:435-8.
55.
Licata G., Scaglione R., Ganguzza A. et al. Central obesity and hypertension: Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. Am J Hypertens1994;7:314-20.
56.
Giacchetti G. , Faloia E., Sardu C. et al. Gene expression of angiotensinogen in adipose tissue of obese patients. Int J Obesity (2000)24 (Suppl 2):S142-S143.
57.
Tamura K., Umemura S., Yamakawa T. et al. Modulation of tissue angiotensinogen gene expression in genetically obese hypertensive rats. Am J Physiol1997 ;272:R1704-R1711.
58.
Alonso-Galicia M., Brands MW, Zappe DH, Hall JEHypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension1996;28:1047-54.
59.
Harker CT, O'Donnell MP, Kasiske BL, Keane WF, Katz SAThe renin-angiotensin system in the type II diabetic obese Zucker rat. J Am Soc Nephrol1993;4:1354-61.
60.
Sowers JR, Nyby M., Stern N. et al. Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension1982;4:686-91.
61.
Tuck ML, Sowers J., Dornfeld L., Kledzik G., Maxwell M.The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med1981;304:930-3.
62.
Marks P., Wilson B., Delassalle A.Aldosterone studies in obese patients with hypertension. Am J Med Sci1985;289:2248.
63.
AN.Effect of weight reduction on the renin-aldosterone axis. J Am Coll Nutr1985;4:225-31.
64.
Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJVisceral obesity and insulin resistance are associated with plasma aldosterone levels in women . Obes Res1999;7:355-62.
65.
Van de Borne P.,Watrin I., Bouquegneau M. et al.Ambulatory blood pressure and neuroendocrine control after diet-assisted gastric restrictive surgery. J Hypertens2000;18:301-6.
66.
Jonsson JR, Game PA, Head RJ, Frewin DBThe expression and localisation of the angiotensin-converting enzyme mRNA in human adipose tissue. Blood Press1994;3:72-5.
67.
Crandall DL , Herzlinger HE, Saunders BD, Armellino DC, Kral JGDistribution of angiotensin II receptors in rat and human adipocytes. J Lipid Res1994 ;35:1378-85.
68.
Jones BH, Standridge MK, Taylor JW, Moustaïd N.Angiotensinogen gene expression in adipose tissue:Analysis of obese models and hormonal and nutritional control. Am J Physiol1997;273:R236-R242.
69.
Karlsson C. , Lindell K., Ottosson M. et al. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab1998 ;83:3925-9.
70.
Schling P., Mallow H., Trindl A., Loffler G.Evidence for a local renin angiotensin system in primary cultured human preadipocytes .IntJObes1999;23:336-41.
71.
Engeli S., Gorzelniak K., Kreutz R., Runkel N., Distler A., SharmaAMCo-expression of renin-angiotensin system genes in human adipose tissue . J Hypertens1999;17:555-60.
72.
Engeli S., Negrel R., SharmaAMPhysiology and pathophysiology of the adipose tissue renin-angiotensin system . Hypertension2000;35:1270-7.
73.
Phillips MI , Speakman EA, Kimura B.Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept1993; 43:1-20.
74.
Frederich RC , Hamann A., Anderson S. et al. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med1995;1:950-3.
75.
Tanimoto K. , Sugiyama F., Goto Y. et al. Angiotensinogen-deficient mice with hypotension. J Biol Chem1994;269:31334-7.
76.
Massiéra F. , Murakami K., Fukamizu A. et al.Angiotensinogen produced by adipose tissue is secreted in blood circulation (Abstract). Int J Obes2000;24 (Suppl 1):S18.
77.
Darimont C. ,Vassaux G.,Ailhaud G., Negrel R.Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology1994 ;135:2030-6.
78.
Crandall DL , Armellino DC, Busler DE, McHendry-Rinde B., Kral JGAngiotensin II receptors in human preadipocytes: role in cell cycle regulation.Endocrinology1999;140:154-8.
79.
Janke J., Gorzelniak K., Engeli S., SharmaAMAngiotensin II inhibts in vitro differentiation of human preadipocytes (Abstract) .IntJObes2000;24 (Suppl 1):S47.
80.
Jones BH, Standridge MK, Moustaid N.Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells . Endocrinology1997;138:1512-9.
81.
Axelrod L., Minnich AK, Ryan CAStimulation of prostacyclin production in isolated rat adipocytes by angiotensin II, vasopressin, and bradykinin: evidence for two separate mechanisms of prostaglandin synthesis. Endocrinology1985;116:2548-53.
82.
Darimont C. , Vassaux G., Gaillard D., Ailhaud G., Negrel R.In situ microdialysis of prostaglandins in adipose tissue: stimulation of prostacyclin release by angiotensin II. Int J Obes1994;18:783-8.
83.
Engeli S., Janke J., Ketteler M., Gorzelniak K., SharmaAMNitric oxide system genes and formation of nitric oxide in human adipose tissue (Abstract).IntJObes2000;24 (Suppl 1): S28.
84.
Cassis LAAngiotensin II in brown adipose tissue from young and adult Zucker obese and lean rats. Am J Physiol1994;266:E453-E458.
85.
Cassis LA, Dwoskin LPAcute and chronic losartan administration: effect on angiotensin II content and modulation of [3H]norepinephrine release from rat interscapular brown adipose tissue. J Neural Transm Gen Sect1994 ;98:159-64.
86.
Cassis LARole of angiotensin II in brown adipose thermogenesis during cold acclimation . Am J Physiol1993;265:E860-E865.
87.
Cassis LA, Dwoskin LPPresynaptic modulation of neurotransmitter release by endogenous angiotensin II in brown adipose tissue. J Neural Transm Suppl1991;34:129-37.
88.
English V., Cassis L.Facilitation of sympathetic neurotransmission contributes to angiotensin regulation of body weight. J Neural Transm1999;106:631-44.
89.
Frederich RCJ , Kahn BB, Peach MJ, Flier JSTissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension1992;19:339-44.
90.
Ernsberger P., Koletsky RJ, Baskin JS, Collins LAConsequences of weight cycling in obese spontaneously hypertensive rats. Am J Physiol1996;270:R864-R872.
91.
Ernsberger P., Nelson DORefeeding hypertension in dietary obesity . Am JPhysiol1988;254:R47-R55.
92.
Aubert J., Safonova I., Negrel R., Ailhaud G.Insulin down-regulates angiotensinogen gene expression and angiotensinogen secretion in cultured adipose cells. Biochem Biophys Res Commun1998;250:77-82.
93.
Safonova I. , Aubert J., Negrel R., Ailhaud G.Regulation by fatty acids of angiotensinogen gene expression in preadipose cells. Biochem J1997;322:235-9.
94.
Aubert J., Darimont C., Safonova I., Ailhaud G., Negrel R.Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells. Biochem J1997 ;328:701-6.
95.
Murakami E. , Hiwada K., Kokubu T.Effects of insulin and glucagon on production of renin substrate by the isolated rat liver. J Endocrinol1980;85:151-3.
96.
Cassis LADownregulation of the renin-angiotensin system in streptozotocin-diabetic rats. Am J Physiol1992;262:E105-E109.
97.
Hainault I. , Oppert JM, Basdevant A., Coussieu C., Guy-Grand B., Quignard-Boulangé A.Evidence of AGT and TNF-a secretion by human adipocytes from obese patients (Abstract) . Eating Weight Dis1999;4:31.
98.
Hennes MMI , O'Shaughnessy IM, Kelly TM, LaBelle P., Egan BM, Kissebah AHInsulin-resistant lipolysis in abdominally obese hypertensive individuals - Role of the renin-angiotensin system. Hypertension1996;28:120-6.
99.
Egan BM, Lu G., Greene ELVascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster. Prostaglandins Leukot Essent Fatty Acids1999;60:411-20.
100.
Carretero OA, Miyazaki S., Scicli AGRole of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril . Hypertension1981;3:18-22.
101.
Carvalho CR , Thirone AC, Gontijo JA, Velloso LA, Saad MJEffect of captopril, losartan, and bradykinin on early steps of insulin action. Diabetes1997;46:1950-7.
102.
Auch-Schwelk W., Duske E., Claus M., Graf K., Grafe M., Fleck E.Endothelium-mediated vasodilation during ACE inhibition. Eur Heart J1995;16 (Suppl C):59-65.
103.
Andersson K., Gaudiot N., Ribiere C., Elizalde M., Giudicelli Y., Arner P.A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo. Br J Pharmacol1999;126:1639-45.
104.
Gaudiot N. , Jaubert AM,Charbonnier E. et al. Modulation of white adipose tissue lipolysis by nitric oxide. J Biol Chem1998 ;273:13475-81.
105.
Soltis EE, Cassis LAInfluence of perivascular adipose tissue on rat aortic smooth muscle responsiveness . Clin Exp Hypertens [A]1991;13:277-96.
106.
Barton M., Carmona R., Morawietz H. et al. Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin . Hypertension2000;35:329-36.
107.
Van Harmelen V., Elizalde M., Ariapart P. et al. The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity. Int J Obes2000;24:673-8.
108.
Van Harmelen V., Ariapart P., Hoffstedt J., Lundkvist I., Bringman S., Arner P.Increased adipose angiotensinogen gene expression in human obesity. Obes Res2000;8:337-41.
109.
Crandall DL, Herzlinger HE, Saunders BD, Kral JGDevelopmental aspects of the adipose tissue renin-angiotensin system: Therapeutic implications. Drug Dev Res1994;32:117-25.
110.
Tamura K., Umemura S., Nyui N. et al. Tissue-specific regulation of angiotensinogen gene expression in spontaneously hypertensive rats.Hypertension1996;27:1216-23.
111.
Nyui N., Tamura K.,Yamaguchi S. et al.Tissue angiotensinogen gene expression induced by lipopolysaccharide in hypertensive rats. Hypertension1997;30:859-67.
112.
Turban S., Hainault I.,André J., Quignard-BoulangéA., Guerre-Millo M.Differential regulation of leptin and AGT secretion in rat adipose cells (Abstract) . Eating Weight Dis1999;4:34.
113.
Cassis LA, Fettinger MJ, Roe AL, Shenoy UR, Howard G.Characterization and regulation of angiotensin II receptors in rat adipose tissue - Angiotensin receptors in adipose tissue. Adv Exp Med Biol1996;396:39-47.
114.
Ardévol A. , Rayner DV, Duncan JS, Trayhurn P.Sympathetic blockade with a-MPT counteracts the inhibitory effects of fasting on leptin production (Abstract). Int J Obesity1999 ;23 (Suppl 5):S23.
